Iambic Therapeutics

IPO
Biotech

Iambic aims for $135M IPO to push cancer drugs through clinic

Iambic Therapeutics aims to raise $135 million in net proceeds from an IPO as it looks to fund the clinical development of its lead cancer drug.
James Waldron Oct 8, 2026 8:45am
IPO initial public offering Wall Street

Iambic maintains momentum from Big Pharma collabs with IPO plans

Sep 22, 2026 3:14am